Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)
All News about Hims & Hers Health, Inc. Class A Common Stock
Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
November 06, 2026
From Hims & Hers
Via Business Wire
Via MarketBeat
The $294 Billion Peptide Boom: Biotech Companies Positioned for the Next Wave of Growth
October 29, 2026
From FN Media
Via GlobeNewswire
Via NewMediaWire
Topics
Lawsuit